All posts by: SetPoint Medical (Admin)

About SetPoint Medical (Admin)

SetPoint Secures $30 Million Series D Equity Financing

  – Funding supports clinical momentum; enables upcoming phase 2 trial in rheumatoid arthritis – Valencia, CA – August 28, 2017 – SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, announced today that it has secured $30 million in Series D equity financing. The Series D financing will … Continue reading

SetPoint Medical Appoints Terry Bevirt as VP of Clinical Affairs

  – Deep Expertise Will Guide SetPoint Bioelectronic Medicine Platform Clinical Programs – Valencia, CA  – July 31, 2017 – SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of Terry Bevirt as Vice President of Clinical Affairs. Ms. Bevirt brings more than 20 years … Continue reading

SetPoint Medical Appoints David Chernoff, MD as Chief Medical Officer

  – Brings Clinical Leadership as SetPoint Advances its Bioelectronic Medicine Platform – Valencia, CA  – June 15, 2017 – SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of David Chernoff, MD as Chief Medical Officer. Dr. Chernoff is a molecular diagnostics and biopharmaceutical … Continue reading

Senior Field Clinical Engineer

Position Description: SetPoint Medical is seeking an experienced, high caliber Senior Field Clinical Engineer (Sr. FCE) to help us with an exciting device study. The Sr. FCE will be responsible for supporting the SetPoint system in a clinical setting, by providing clinical consultation, teaching and support on the use of the system and its appropriate … Continue reading

Global Venture Firm NEA Joins SetPoint Medical Syndicate of Investors

  – NEA General Partner Josh Makower, MD Added to SetPoint Board of Directors – Valencia, CA – March 20, 2017 – SetPoint Medical, a biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, announced that global venture capital firm New Enterprise Associates, Inc. (NEA) has joined the syndicate of SetPoint Medical investors, … Continue reading